Su, CP, HJ Chai, YS See, and R Sures Kumar. 2024. “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF SGLT2 INHIBITORS (EMPAGLIFLOZIN 25 MG, EMPAGLIFLOZIN 12.5 MG AND DAPAGLIFLOZIN 10 MG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SINGLE CENTRE STUDY”. Journal of the ASEAN Federation of Endocrine Societies 39 (S1):25. https://doi.org/10.15605/jafes.039.S1.037.